United States - English - NLM (National Library of Medicine)

hospira, inc. - potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152) - potassium acetate 3.93 g in 20 ml - potassium acetate injection, usp, 40 meq is indicated as a source of potassium, for the addition to large volume intravenous fluids, to prevent or correct hypokalemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. potassium administration is contraindicated in patients with severe renal insufficiency or adrenal insufficiency and in diseases where high potassium levels may be encountered.

United States - English - NLM (National Library of Medicine)

exela pharma sciences, llc - potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152) - potassium acetate injection, usp (2 meq/ml) is indicated as a source of potassium, for the addition to large volume intravenous fluids, to prevent or correct hypokalemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. potassium administration is contraindicated in patients with severe renal insufficiency or adrenal insufficiency and in diseases where high potassium levels may be encountered.

United States - English - NLM (National Library of Medicine)

hospira, inc. - potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152) - potassium acetate injection, usp (2 meq/ml) is indicated as a source of potassium, for the addition to large volume intravenous fluids, to prevent or correct hypokalemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. potassium administration is contraindicated in patients with severe renal insufficiency or adrenal insufficiency and in diseases where high potassium levels may be encountered.

United States - English - NLM (National Library of Medicine)

exela pharma sciences, llc - potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152) - potassium acetate 3.93 g in 20 ml - potassium acetate injection, usp is indicated as a source of potassium, for the addition to large volume intravenous fluids, to prevent or correct hypokalemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. potassium administration is contraindicated in patients with severe renal insufficiency or adrenal insufficiency and in diseases where high potassium levels may be encountered.

United States - English - NLM (National Library of Medicine)

hospira, inc. - potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152) - potassium acetate injection, usp, 40 meq is indicated as a source of potassium, for the addition to large volume intravenous fluids, to prevent or correct hypokalemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. potassium administration is contraindicated in patients with severe renal insufficiency or adrenal insufficiency and in diseases where high potassium levels may be encountered.

United States - English - NLM (National Library of Medicine)

hospira, inc. - potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152) - potassium acetate injection, usp (2 meq/ml) is indicated as a source of potassium, for the addition to large volume intravenous fluids, to prevent or correct hypokalemia in patients with restricted or no oral intake. it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. potassium administration is contraindicated in patients with severe renal insufficiency or adrenal insufficiency and in diseases where high potassium levels may be encountered.

United States - English - NLM (National Library of Medicine)

dna labs, inc. - potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152), antimony trisulfide (unii: f79059a38u) (antimony trisulfide - unii:f79059a38u), saffron (unii: e849g4x5yj) (saffron - unii:e849g4x5yj), umbilicus rupestris (unii: x68txr7v4y) (umbilicus rupestris - unii:x68txr7v4y), corallium rubrum exoskeleton (unii: 2ca71k0dle) (corallium rubrum exoskeleton - unii:2ca71k0dle), bos taurus pancreas (unii: 1m529tnt1d) (bos taurus pancreas - unii:1m529tnt1d), quercus alba wood (unii: xr6bc2zuam) - supports the pancreas.

United States - English - NLM (National Library of Medicine)

american regent, inc. - potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152) - potassium acetate 196 mg in 1 ml

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium acetate (unii: 4550k0sc9b) (acetate ion - unii:569dqm74sc, sodium cation - unii:lyr4m0nh37), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - potassium acetate 1.96 g in 20 ml - hyperlyte® cr is indicated for use as a supplement to parenteral nutritional solutions containing amino acids, dextrose and/or other calorie sources delivered by central venous or peripheral infusion, to facilitate amino acid utilization and maintain electrolyte balance in adults. hyperlyte® cr (multi-electrolyte concentrate) is also indicated as a source of replacement electrolytes for the depleted adult patient during parenteral therapy. hyperlyte® cr is contraindicated in clinical conditions where the administration of potassium, sodium, calcium, magnesium, or chloride could be clinically detrimental. hyperlyte® cr is not intended for pediatric use.

United States - English - NLM (National Library of Medicine)

icu medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium acetate (unii: m911911u02) (potassium cation - unii:295o53k152), magnesium acetate (unii: 0e95jzy48k) (magnesium cation - unii:t6v3lhy838) - normosol-m and 5% dextrose injection (multiple electrolytes and 5% dextrose injection type 1, usp) is indicated for parenteral maintenance of routine daily fluid and electrolyte requirements with minimal carbohydrate calories from dextrose. magnesium in the formula may help to prevent iatrogenic magnesium deficiency in patients receiving prolonged parenteral therapy. none known.